Kestra Advisory Services’s Pfizer PFE Stock Holding History

Kestra Advisory Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.4M	Sell	1,884,553 -70,042	-4%	-$1.83M	0.15%	135
2026 Q1	$54.9M	Buy	1,954,595 +249,309	+15%	+$6.64M	0.21%	91
2025 Q4	$42.5M	Buy	1,705,286 +128,543	+8%	+$3.24M	0.17%	108
2025 Q3	$40.2M	Buy	1,576,743 +167,227	+12%	+$4.13M	0.18%	103
2025 Q2	$34.2M	Buy	1,409,516 +268,402	+24%	+$6.26M	0.17%	110
2025 Q1	$28.9M	Sell	1,141,114 -21,143	-2%	-$553K	0.14%	116
2024 Q4	$30.8M	Sell	1,162,257 -152,429	-12%	-$4.13M	0.17%	114
2024 Q3	$38M	Sell	1,314,686 -44,722	-3%	-$1.3M	0.21%	92
2024 Q2	$35.9M	Buy	1,359,408 +372,152	+38%	+$10.2M	0.2%	91
2024 Q1	$27.4M	Buy	987,256 +288,602	+41%	+$8.01M	0.18%	110
2023 Q4	$20.1M	Sell	698,654 -37,880	-5%	-$1.15M	0.16%	117
2023 Q3	$24.4M	Buy	736,534 +22,036	+3%	+$779K	0.24%	85
2023 Q2	$26.2M	Buy	714,498 +153,170	+27%	+$5.96M	0.26%	77
2023 Q1	$22.9M	Sell	561,328 -165,093	-23%	-$7.13M	0.25%	83
2022 Q4	$37.2M	Sell	726,421 -11,601	-2%	-$556K	0.33%	54
2022 Q3	$32.3M	Buy	738,022 +86,449	+13%	+$4.2M	0.35%	56
2022 Q2	$34.2M	Buy	651,573 +95,704	+17%	+$4.88M	0.35%	51
2022 Q1	$28.8M	Sell	555,869 -81,224	-13%	-$4.21M	0.3%	64
2021 Q4	$37.6M	Sell	637,093 -144,208	-18%	-$7.14M	0.38%	51
2021 Q3	$33.6M	Buy	781,301 +151,936	+24%	+$6.73M	0.34%	58
2021 Q2	$24.6M	Sell	629,365 -530	-0.1%	-$20.6K	0.28%	75
2021 Q1	$22.8M	Sell	629,895 -218,714	-26%	-$7.77M	0.29%	75
2020 Q4	$31.2M	Buy	848,609 +324,164	+62%	+$11.9M	0.36%	55
2020 Q3	$18.3M	Buy	+524,445	New	+$18.4M	0.34%	61

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Kestra Advisory Services's PFE Position: Q2 2026 in Review

Kestra Advisory Services reduced its Pfizer (PFE) stake by 3.6% in Q2 2026, selling an estimated $1.83M and leaving 1,884,553 shares worth $45.4M. The position accounts for 0.15% of the portfolio, ranked #135.

Kestra Advisory Services first reported a position in PFE in Q3 2020 and has held it in 24 quarters since. The position peaked at $54.9M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Kestra Advisory Services held 1,884,553 shares of Pfizer worth $45.4M as of Q2 2026.
Kestra Advisory Services sold 70,042 Pfizer shares in Q2 2026, an estimated $1.83M.
Pfizer made up 0.15% of Kestra Advisory Services's portfolio in Q2 2026, its #135 holding.
Kestra Advisory Services first reported a position in Pfizer in Q3 2020 and has held it in 24 quarters since.
Kestra Advisory Services's Pfizer position peaked at $54.9M in Q1 2026.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.